$NRGV

Top insider buys and sells disclosed for Thursday

Energy Vault (NRGV) director bought 27,472 shares at $3.88 each. Keurig Dr Pepper (KDP) director acquired 7,862 shares at $31.83. Welltower (WELL) director purchased 10,000 shares at $239.47-$242.06. American Assets (AAT) chairman bought 79,729 shares at $22.74-$22.89. Lumentum (LITE) exec sold 38,604 shares at $842.22-$860.05. Tempus AI (TEM) CEO sold 238,052 shares at $64.03-$70.58. CoreWeave (CRWV) CEO sold 307,692 shares at $88.31-$89.93. Illumina (ILMN) director sold 375,541 shares at $224.

Original reporting
Published Aug 28, 2026, 1:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 1:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$NRGV
Bullish
medium confidence
Mentioned
$NRGV · $KDP · $WELL · $AAT · $LITE · $TEM
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$NRGVBullishLow
01

Why it matters

Aggregated insider activity provides a snapshot of executive sentiment, with mixed signals across sectors.

02

Market read

Insider trades can influence short‑term price dynamics; the mix of large buys and sells offers traders nuanced signals.

03

What to watch

Option exercises and trust structures can mask true intent; some buys may be tax‑driven rather than confidence signals.

Relevance 6/10Novelty 7/10Timing: Thursday Aug 27, 2026

Background

The article aggregates recent Form 4 filings, highlighting notable insider purchases and sales for Thursday, Aug 27 2026.

Company-level read

Ticker impact

$NRGVBullishMedium confidence
Context

Director Dylan Hixon purchased 27,472 shares at $3.878 each, indicating confidence despite overvaluation.

Expected impact

Modest upside if market perceives confidence.

Evidence & confidence

Buy size relative to float is modest but signals insider belief.

$KDPBullishMedium confidence
Context

Director Aaron Alt bought 7,862 shares at $31.83, suggesting belief in undervaluation.

Expected impact

Slight upward pressure.

Evidence & confidence

Purchase size is small relative to market cap.

$WELLBullishMedium confidence
Context

Director Andrew Gundlach bought 10,000 shares for $2.41 M, reinforcing confidence near 52‑week high.

Expected impact

Potential short‑term rally.

Evidence & confidence

Significant dollar amount and proximity to high.

$AATBullishMedium confidence
Context

Executive Chairman Ernest Rady bought 79,729 shares for $1.82 M, indicating confidence in undervalued stock.

Expected impact

Modest upside.

Evidence & confidence

Large purchase by a 10% owner is noteworthy.

$LITEBearishMedium confidence
Context

Executive VP Vincent Retort sold 38,604 shares for $32.96 M under a 10b5‑1 plan.

Expected impact

Potential short‑term dip.

Evidence & confidence

Sale size is material; market may view as lack of confidence.

$TEMBearishMedium confidence
Context

CEO Eric Lefkofsky sold 238,052 shares for $16.29 M via 10b5‑1 plan.

Expected impact

Possible downside pressure.

Evidence & confidence

CEO sell size is large relative to market.

$CRWVBearishMedium confidence
Context

CEO Michael Intrator sold 307,692 shares for $27.3 M under a 10b5‑1 plan.

Expected impact

Downward pressure.

Evidence & confidence

CEO sale amount is material.

$ILMNBearishMedium confidence
Context

Director Keith Meister sold 375,541 shares for $85.2 M over three days.

Expected impact

Potential price decline.

Evidence & confidence

Large dollar value and multiple-day execution.

Market effects

Insider activity across consumer staples, tech, and industrials may signal sector‑wide confidence trends.

U.S. market sentiment may be modestly affected as multiple large‑cap names report insider moves.

Limited; primarily U.S. equity market focus.

Counterpoint

Large insider sells may be routine 10b5‑1 plans, not necessarily bearish.

Key entities

  • Dylan Hixon

    Director of Energy Vault Holdings who bought shares.

  • Aaron Alt

    Director of Keurig Dr Pepper who bought shares.

  • Vincent Retort

    Lumentum executive who sold shares under a 10b5‑1 plan.

Related articles

$CRWVMed

Top Wall Street analysts are upbeat about the prospects for these 3 stocks

Wall Street analysts highlight three stocks with growth prospects: CoreWeave (CRWV) upgraded to buy with a $125 target by JPMorgan, citing strong demand and pricing; Palo Alto Networks (PANW) reiterated as buy with a $425 target by BTIG, expecting revenue growth above consensus; Amazon (AMZN) raised to $360 by Rosenblatt, dismissing AI threats to its advertising business.

Med

Lumentum Stock $1,085: Bull $1,400, Bear $920

Lumentum's stock closed at $1,085.42 on Friday, up 3.79%, following a 7.67% gain on Thursday. Analysts Bernstein and Citi set targets at $1,220 and $1,400 respectively. The company reported fiscal Q4 2026 revenue of $1.01 billion, up 109.3%, and guided fiscal Q1 2027 revenue to $1.225–$1.275 billion. The stock's rally was driven by Bernstein's coverage initiation and reports of US scrutiny on Chinese optical transceivers.

$EWHighAI 8/10

Weekly Buzz: EW, ABBV, MIRM Score FDA Wins, AZN, NVO Strike Deals; LLY, KOD Report Data

Edwards Lifesciences (EW) received FDA approval for a pediatric heart valve. Ceribell (CBLL) and SI-BONE (SIBN) cleared new software and spinal fusion systems. Teva (TEVA) added a biosimilar to its portfolio. AbbVie (ABBV) and Mirum (MIRM) gained FDA approvals for Parkinson's and rare disease treatments. Merck (MRK) withdrew a lung cancer drug filing. Sanofi (SNY) and Regeneron (REGN) expanded their immunology alliance.

$AMZNMed

AI Debt Is a ‘Brewing Crisis,’ Ed Zitron Warns as Amazon, CoreWeave Turn to Complex Financing

AI skeptic Ed Zitron warns of a 'brewing crisis' in AI-related debt, citing higher borrowing costs and delays. Amazon (AMZN) may use complex financing for $8B of Nvidia (NVDA) chips. Goldman Sachs reports $88B in lower-rated AI-related borrowing. CoreWeave (CRWV) has $35.6B in debt, relying on private credit. Zitron estimates CoreWeave's debt costs could reach 13%. Anthropic's revenue growth challenges Zitron's earlier predictions, but financing remains a concern.